Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K2MT
|
||||
Former ID |
DIB007272
|
||||
Drug Name |
ADC-7828
|
||||
Synonyms |
ADC-7828; Neutrophil elastase inhibitors (inhaled, CF/COPD); Neutrophil elastase inhibitor (inhaled, cystic fibrosis/chronic obstructive pulmonary disease), Argenta; Neutrophil elastase inhibitors (inhaled, CF/COPD), Argenta; Neutrophil elastase inhibitors (inhaled, CF/COPD), Pulmagen
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Investigative | [1] | ||
Company |
Argenta Discovery Ltd
|
||||
Target and Pathway | |||||
Target(s) | Leukocyte elastase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Transcriptional misregulation in cancer | ||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
C-MYB transcription factor network | |||||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | ||||
Human Complement System | |||||
Degradation of collagen | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2358). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.